NanoSphere Health Sciences Inc.
NSHSF
$0.0038
-$0.0362-90.50%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 44.40K | 44.50K | 26.50K | 44.40K | 45.10K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 44.40K | 52.10K | 28.00K | 57.00K | 49.40K |
Operating Income | -44.40K | -52.10K | -28.00K | -57.00K | -49.40K |
Income Before Tax | -41.70K | -61.10K | -41.30K | -54.90K | -41.50K |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -41.70K | -61.10K | -41.30K | -54.90K | -41.50K |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -41.70K | -61.10K | -41.30K | -54.90K | -41.50K |
EBIT | -44.40K | -52.10K | -28.00K | -57.00K | -49.40K |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Basic Shares Outstanding | 10.28M | 10.28M | 10.28M | 10.28M | 10.28M |
Average Diluted Shares Outstanding | 10.28M | 10.28M | 10.28M | 10.28M | 10.28M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |